login

A molecular variant of angiotensinogen associated with preeclampsia

Nature GeneticsPublished 1 May 1993
Kevin R. Ward, Akira Hata, Xavier Jeunemaı̂tre, Catherine Helin, Lawrence M. Nelson, Chisato Namikawa
Citations504
SJR quartileQ1
SJR score16.59
SNIP6.64

TL;DR

In a series of Caucasian women with pregnancy–induced hypertension, a significant association of preeclampsia with a molecular variant of angiotensinogen, T235, found previously to be associated with essential hypertension is observed, which support a new pathophysiological interpretation of preeClampsia and of its relation to some forms of essential hypertension.

Abstract

Pregnancy-induced hypertension (PIH) is a heterogeneous disorder which complicates 5-7% of all pregnancies and remains a leading cause of maternal, fetal and neonatal morbidity and mortality. Severe preeclampsia is the most distinctive and life-threatening form; a multi-system disorder more common in first pregnancies, it is characterized by high blood pressure and proteinuria. In a series of Caucasian women with pregnancy-induced hypertension, we have observed a significant association of preeclampsia with a molecular variant of angiotensinogen, T235, found previously to be associated with essential hypertension. This finding is corroborated in a sample ascertained in Japan. Together, these observations support a new pathophysiological interpretation of preeclampsia and of its relation to some forms of essential hypertension.

Keywords

Medicine